Bioxyne
- Short interest
- 0.02%
- −0.02 pp 30d
- as of 6 July 2026
- Reported shorts
- 50K
- Shares on issue
- 229.978M
Bioxyne (BXN) Short Interest
Bioxyne (ASX:BXN) had 0.02% of shares reported as short positions as of 6 July 2026, representing 50,000 shares. Bioxyne operates in the Household & Personal Products industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Bioxyne
Bioxyne is an international healthcare, life sciences, and novel medicines development company with operations in Australia, the United Kingdom, Japan, Czechia, Germany, and the United States. They focus on investigational & psychotropic medicines, healthcare technology, and novel consumer health products, aiming to revolutionize healthcare approaches.
Company profile →Bioxyne (ASX:BXN) has 0.02% of its shares on issue reported as short positions as of 6 July 2026, or about 50,000 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.86% in May 2014. BXN is classified in the Household & Personal Products industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads BXN today
- Zanger BreakoutWatchScore 23rank 1078 of 1942
- CAN SLIMWatchScore 20rank 737 of 1541
- Minervini Trend TemplateWatchScore 79rank 116 of 1716
- Crowded-Short BreakoutWatchScore 15rank 597 of 1500
- Quality compoundersWatchScore 15rank 953 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
Latest BXN news
All news- Why Is Bioxyne (ASX:BXN) Drawing Market Attention?
kalkine · 10 Aug 2026
- Agreement with Trexapharm for Commercialisation of Trexavive
asx · 21 July 2026
- BLS Strengthens Gobal Psychedelic Medicines Platform
asx · 20 July 2026
Company details
website
address
More Household & Personal Products Stocks
Other shorted stocks in this sector
Be the first to discuss BXN
Start a research thread or post the first pulse update